Startups

BrainCheck
Austin, Texas, United States · Houston, Texas, United States
BrainCheck, Inc. develops digital cognitive assessment and care software for healthcare providers. Its platform supports screening, structured cognitive assessments, longitudinal monitoring and personalized care planning for cognitive impairment, Alzheimer’s disease and related dementias. The company applies computational neuroscience and AI to scoring, clinical workflows, population analytics and research on earlier detection; funded projects include an AI companion for cognitive-care plans, AI assessment algorithms and an eConsult platform connecting primary-care clinicians with dementia specialists. BrainCheck Assess is identified by the company as an FDA Class II medical device intended for qualified healthcare-professional interpretation. It is not a standalone diagnostic device and does not establish the presence or absence of a clinical diagnosis. Screen, Plan and screeners are not regulated devices. Co-founders David Eagleman and Yael Katz established the business, and Chris Loughlin became CEO in October2024. Its current published leadership and scientific sources identify executives, directors, advisers and researchers, with historical or unverified current affiliations explicitly qualified. Verified financing includes an initial USD3 million raise, an aggregate USD8 million Series A whose earlier components are not counted again, USD10 million Series B in2021, USD15 million new financing in2024 and an additional USD13 million financing in February2026 that the issuer itself labels Series A. Research grants are recorded separately from venture funding, and inconsistent historical cumulative totals are not treated as new cash.



















